Business Standard

Bacil Pharma Ltd Announcements

BY EXCHANGE :

ANNOUNCEMENTSUBJECTATTACHMENTBROADCAST DATE
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance Certificate under 74(5) of SEBI (DP) Regulation 201811/04/2024
Closure of Trading Window Closure of Trading Window29/03/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to Reg 39(3) of SEBI (LODR) Regulation 2015 we have received an intimat...Read More12/03/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper publication14/02/2024
Unaudited Financial Results For The Quarter And Nine Months Ended 31St December2023 Unaudited Financial Result for the quarter and nice months ended 31st December 2...Read More13/02/2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th February2024 Approved and adopted the Un-audited Financial Results along with Limited Review ...Read More13/02/2024
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 31St December2023 BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of ...Read More03/02/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance certificate under regulation 74 of SEBI (DP) Regulation 201816/01/2024
Annual General Meeting To Be Held On 16Th September2023. Annual General Meeting to be held on 16th September202324/08/2023
Reg. 34 (1) Annual Report. Submission of Annual Report for the F.Y. 2022-2324/08/2023
Intimation Of Shareholders Annual General Meeting To Be Held On 16Th September2023 Intimation of Annual General Meeting to be held on 16th September202324/08/2023
Intimation Of Book Closure For The Annual General Meeting To Be Held On 16Th September2023 Intimation of Book Closure for the Annual General Meeting to be held on 16th Sep...Read More24/08/2023
Intimation Of Record Date For The Annual General Meeting Intimation of Record Date for the Annual General Meeting to be held on 16th Sept...Read More24/08/2023
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 30Th June2023 Along With Limited Review Report And Other Business. BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of ...Read More07/08/2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 REG. 74(5) FOR THE QUARTER ENDED 30TH JUNE 2023.11/07/2023
Closure of Trading Window Intimation of closure of Trading Window for the quarter ended 30th June202330/06/2023
Board Meeting Intimation for Intimation Of Board Meeting For Approval Of The Audited Financial Results For The Quarter And Year Ended 31St March 2023. BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of ...Read More08/05/2023
REG-7(3)_COMPLIANCE CERTIFICATE FOR THE QUARTER ENDED 31ST MARCH2023. REG-7(3)_COMPLIANCE CERTIFICATE FOR THE QUARTER ENDED 31ST MARCH2023.26/04/2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 COMPLIANCE CERTIFICATE UNDER REG. 74(5) FOR THE QUARTER AND YEAR ENDED 31ST MARC...Read More22/04/2023
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 <b>Format of the Annual Disclosure to be made by an entity identified as a Large...Read More22/04/2023

Load more